HEALTH COMMUNICATIONS The Health Communications Core (HCC) of the University of Michigan Comprehensive Cancer Center (UMCCC) is a new service that will provide the communications and communications technology support and capacity to UMCCC investigators. The interactions between the HCC and investigators are intended to maximize the internal validity and scientific integrity to the communications components of interventions, clinical trial recruitment of underserved populations, and adherence to therapeutic and non-therapeutic protocols. Domains of HCC support will focus on cancer prevention, cancer control, and clinical research endeavors. The HCC will be housed in the University of Michigan Center for Health Communications Research, an organization with a history of providing a coordination of resources, economy of scale, and product sophistication that would not be feasible through more independent outside vendor models. The HCC will work with UMCCC investigators to: 1) Assist with communications and technological analysis of their intervention, recruitment, and/or retention needs; 2) Design, develop, deploy, and maintain high-quality print-, hand-held device, web-based, or other relevant communications channels and strategies; 3) Disseminate knowledge of advanced health communication interventions to researchers, practitioners, other NCI Centers, and other parties interested in advanced cancer communications. The HCC will rely on a successful production and quality assurance model used in advanced health communications since 1997 at the University of Michigan. This new core strengthens and institutionalizes a long-standing commitment by the Center for Health Communications Research to provide a robust resource for Cancer Center investigators committed to providing the highest quality, innovative, health communications tailored to the needs of individuals and special populations.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA046592-21
Application #
7726839
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2008-06-01
Budget End
2009-05-31
Support Year
21
Fiscal Year
2008
Total Cost
$138,244
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Khoriaty, Rami; Hesketh, Geoffrey G; Bernard, Amélie et al. (2018) Functions of the COPII gene paralogs SEC23A and SEC23B are interchangeable in vivo. Proc Natl Acad Sci U S A 115:E7748-E7757
Katz, Steven J; Ward, Kevin C; Hamilton, Ann S et al. (2018) Gaps in Receipt of Clinically Indicated Genetic Counseling After Diagnosis of Breast Cancer. J Clin Oncol 36:1218-1224
Ulintz, Peter J; Greenson, Joel K; Wu, Rong et al. (2018) Lymph Node Metastases in Colon Cancer Are Polyclonal. Clin Cancer Res 24:2214-2224
Qin, Tingting; Zhang, Yanxiao; Zarins, Katie R et al. (2018) Expressed HNSCC variants by HPV-status in a well-characterized Michigan cohort. Sci Rep 8:11458
Xu, Shilin; Aguilar, Angelo; Xu, Tianfeng et al. (2018) Design of the First-in-Class, Highly Potent Irreversible Inhibitor Targeting the Menin-MLL Protein-Protein Interaction. Angew Chem Int Ed Engl 57:1601-1605
Crespo, Joel; Wu, Ke; Li, Wei et al. (2018) Human Naive T Cells Express Functional CXCL8 and Promote Tumorigenesis. J Immunol 201:814-820
Manohar, Poorni M; Beesley, Lauren J; Bellile, Emily L et al. (2018) Prognostic Value of FDG-PET/CT Metabolic Parameters in Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer. Clin Nucl Med 43:641-647
Hawley, Sarah T; Li, Yun; An, Lawrence C et al. (2018) Improving Breast Cancer Surgical Treatment Decision Making: The iCanDecide Randomized Clinical Trial. J Clin Oncol 36:659-666
Salami, Simpa S; Hovelson, Daniel H; Kaplan, Jeremy B et al. (2018) Transcriptomic heterogeneity in multifocal prostate cancer. JCI Insight 3:
Smith, Joshua; Kulkarni, Aditi; Birkeland, Andrew C et al. (2018) Whole-Exome Sequencing of Sinonasal Small Cell Carcinoma Arising within a Papillary Schneiderian Carcinoma In Situ. Otolaryngol Head Neck Surg 159:859-865

Showing the most recent 10 out of 1493 publications